甲状腺癌术后乳糜漏的管理
该回顾性研究分析了甲状腺癌术后乳糜漏的发生率与管理模式。共识别131例乳糜漏患者,总体发生率为0.9%。其中43.7%仅接受中央区颈淋巴结清扫而未行侧颈清扫,乳糜漏经保守治疗易于控制;饮食改良后引流量减少>50%者住院时间显著缩短(P < .001),禁食(NPO)是最有效的饮食改良方式。结论认为中央区清扫后乳糜漏并不罕见但保守治疗易控制,若禁食2天后引流量未较发现日原量减少>50%则应考虑手术。
要点
- 甲状腺癌术后乳糜漏总体发生率为0.9%,中央区清扫后亦可发生。
- 饮食改良后引流量减少>50%者住院时间显著缩短(P < .001)。
- 禁食2天后引流量未较发现日减少>50%者应考虑手术治疗。
核心结论
- 甲状腺癌行中央区颈淋巴结清扫后乳糜漏并不罕见,但经保守治疗易于控制。
- 若禁食2天后引流量未较发现日原量减少>50%,应考虑手术处理。
研究设计与样本
- 回顾性分析接受手术治疗的甲状腺癌患者,共识别131例乳糜漏患者。
主要发现
- 乳糜漏总体发生率为0.9%。
- 131例中43.7%仅行中央区颈淋巴结清扫而未行侧颈清扫,乳糜漏经保守治疗易于控制。
- 饮食改良后引流量减少>50%的患者住院时间显著更短(P < .001)。
- 禁食(NPO)是最有效的饮食改良方式。
关键数值与推荐
- 乳糜漏总体发生率为0.9%。
- 饮食改良后引流量减少>50%者住院时间显著缩短(P < .001)。
- 禁食2天后引流量未较发现日原量减少>50%时考虑手术。
临床怎么用
- 甲状腺癌术后应警惕中央区清扫后的乳糜漏,多数可先保守治疗。
- 饮食改良(尤其是禁食)可作为初始管理,引流量减少>50%提示保守治疗有效。
- 禁食2天后引流量未较发现日减少>50%者应及时评估手术干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to evaluate the incidence and pattern of chyle leakage after thyroidectomy and/or cervical lymph node dissection and to establish management protocols for chyle leakage. METHODS: Patients who underwent surgical management for thyroid cancer were analyzed retrospectively. RESULTS: For this study, 131 patients with chyle leakage were identified; the overall incidence was 0.9%. Of them, 43.7% of patients underwent central neck dissection without lateral neck dissection, and chyle leakage was easily controlled with conservative management. Patients whose chyle drainage was reduced by >50% after dietary modification had a significantly shorter hospital stay (P < .001); NPO was the most effective dietary modification. CONCLUSION: The occurrence of chyle leakage after central compartment dissection even without lateral neck dissection was not rare, but was easily controlled with conservative management. Surgical management should be considered if the drainage amount does not decrease by >50% of the original amount of the day of detection after 2 days of NPO.
引用
- Park I, Her N, Choe JH, et al. Management of chyle leakage after thyroidectomy, cervical lymph node dissection, in patients with thyroid cancer. Head Neck. 2017. PMID: 29120521. doi:10.1002/hed.24852
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。